peripheral neuropathy, although nerve conduction studies are not mentioned). This resting tremor is almost invariably accompanied by an additional postural tremor.
Although this 'neuropathic' tremor is well recognized in neurological circles, its pathophysiological basis is unclear, since its presence and severity seem to bear no simple relationship to deafferentation, particularly in respect to posterior column sensation'. Indeed, a central, but immunologically mediated, contribution cannot be entirely ruled out.
Despite this disagreement concerning the underlying defect, I fully agree that every patient with an unusual tremor and signs of a peripheral neuropathy should have their serum proteins (including immunoglobulin levels) determined. Finally The authors reply below:
Dr Quinn provides interesting information regarding tremor in patients with dysgammaglobulinaemic polyneuropathy and he suggests that our patient did indeed have a 'neuropathic' tremor as opposed to a tremor of central origin. While accepting that the chronic sensory lower limb neuropathy in our patient may have been secondary to monoclonal gammopathy, we would stress that the sudden origin of a 'pill-rolling' tremor in the upper limbs coinciding with a grossly elevated plasma viscosity is highly suggestive of a central vascular incident. Dalakas et al.1 suggest that there may be a central contribution (immunologically mediated) to the tremor associated with dysgammaglobulinaemic neuropathy. Their patients, however, tended to improve with immunosuppressive therapy whereas the tremor in our patient did not improve with therapy.
With regard to Dr Quinn's title suggestion, our term 'Parkinsonian' is used adjectively and provides an acceptable description of the tremor: the prefix 'pseudo' suggests a tremor bearing no resemblance to that associated with Parkinson's disease and this would be false in this instance. In addition, the history oflongstanding alcohol abuse precludes the use of the suggested latter half of the title, ie 'dysgammaglobulinaemic neuropathy'. Insight and psychosis We read with interest the discussion paper on Insight and Psychosis by Anthony S David <May 1990 JRSM, p 325). We have been attempting to operationalize the concept of insight in schizophrenic patients, and have devised a scale that quantifies insightlessness, Like Dr David, we consider that insight has several dimensions, including attitude to psychiatric illness both past and present, and attitude to treatment. Dr David's inclusion of the ability of the patient to re-label unusual mental events as pathological, as a separate dimension, is, we believe, appropriate. However, compliance with treatment (along with the patient's response to changing symptoms) should be seen not as dimensions of insight, but rather as related events. As Dr David and others have demonstrated! the correlation between insight and compliance is limited. The mechanisms underlying dimunition of insight remain obscure. Insightlessness may be regarded as: ( 1) a normal phenomenon, insofar as many people demonstrate limited insight into certain characteristics of their personality and behaviour; (2) a defence mechanism (denial);
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(3) a delusional phenomenon; (4) a feature of the schizophrenic defect state: and (5) a specific defect of cognition.
Given that the direct measurement of components of insightlessness is not possible, our scale attempts to derive an overall measure, based on a semistructured interview, concerning the attitude of the patient to five parameters. These are the appropriateness of clinical management and placement, the treatment prescribed, the existence of a psychiatric disorder, the behaviour in response to symptoms, and the attitude to previous episodes of illness. Preliminary findings indicate that the score so derived correlates well with a global clinical impression of insight based on prior knowledge of the patient. This manuscript is a collection oflecture notes, used many times and has various additions which refer to editions of books which appeared between 1616 and 1628. An important addition is a reply to Riolan's Anthropographiae of 1626 in which Riolan said that blowing into the uterine veins will distend the arteries. At that date, Harvey's tentative comment was 'Or does the reverse occur?' Subsequently in De Generatione Harvey confidently asserts that only the reverse does occur, a strong argument for the truth of the circulation. Obviously establishing this truth must have taken many months, perhaps years, and it seems likely that Harvey was not certain of all the ramifications of his discovery even in 1626.
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References Briefly the test depends on the alteration in absolute electrophoretic mobility of well washed red blood cells (RBC) after exposure to emanation from a 0.5 mW He-Ne laser guarded by a Zeiss filter", After irradiation linoleic acid (LA) is added to a final concentration of 0.08 mg/ml and RBC mobility is measured. As control ethanol is used (since LA is made up in ethanol).
If the RBC came from a patient with MS diathesis then they travel more rapidly than control, until at some point between 104 and 110 s exposure to the irradiation there is a sudden transition to control value. Patients with destruction of central nervous system (CNS) tissue from any cause other than MS (other neurological disease, aND) reach break point somewhere between 74 and 81 s, whilst cells from normals do so at 70 s exposure'.
The simplest differentiation is to make an exposure of 90 s which is too long for normals or aND and so the 'break' occurs; but not high enough for MS to break. If the clinical history is consonant with ME then a diagnosis of this disease as an organic lesion of the CNS is clear.
Journal of the Royal Society of Medicine Volume 83 October 1990 675 A long-term substantiation of this simple differential diagnosis is obtainable by exhibition of essential fatty acids which will convert the MS result to normal in about 9 months, whilst the ME type result scarcely changes.
A real difficulty arises when a patient with MS diathesis picks up ME, for an MS diathesis takes precedence over an aND, but such cases are rare. Full details are available in 'Multiple Sclerosis: a conceptual reappraisal with heuristic implications". E J FIELD According to D J D Perrins's letter (June 1990 JRSM, p 413) hyperbaric oxygen was used for treatment on the postviral syndrome (myalgic encephalomyelitis) without apparent knowledge of underlying physiology. If one considers a few of the other labels that have been used to describe the disorder, DaCosta's syndrome, soldier's heart, effort syndrome, neurocirculatory asthenia and hyperventilation syndrome! and their known physiology-the logic of using hyperbaric pressure becomes clear. In one of his 1919 papers" describing the cause of the disorder J S Haldane states 'In fact the patients are in the same state as a normal individual at high altitudes where diminished oxygen tension of the inspired air produces the same series of effects'. If symptoms are compared to those of acute mountain sickness the lists appear interchangeahls".
A hyperbaric environment without oxygen enrichment has been shown to be a successful treatment for the disorder in its more extreme form where neurocirculatory collapse is life threatening5. Its successful use results from accumulating carbon dioxide and carbonic acid which is detrimental for underwater or hyperbaric work" but represents simple replacement for an individual in a hypobaric condition due to a compensated alkalosis", Increased lactic acid production not a result of exercise has been shown to be directly and inversely related to the diminished bicarbonate levels that characterize this disorder/-", Use of 100% oxygen appears inadvisable? and unnecessary" where inadequate oxygen is secondary to reduced carbon dioxide levels (Bohr effect)2 and physical exertion is not a factor. It would appear that longer treatment times, at higher pressure, without additional oxygen would produce faster and better results". B EWING
